PDCD1 and Hyperglycemia: Chronic exposure to hyperglycemia, advanced glycation end products, and pro-inflammatory cytokines may drive TRM exhaustion, marked by upregulation of inhibitory receptors, including PD-1, TIM-3, and LAG-3, thereby weakening protective functions [159].